Current concepts in the pathology and epigenetics of endometrial carcinoma

References

• Strom BL, Schinnar R, Weber AL, et al Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 2006; 164: 775–86.
   PubMed Web of Science ®Google Scholar
• Persson I, Adami HO. Endometrial cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology.New York: Oxford University Press, 2002; 359–77.
   Google Scholar
• Parkin D, Whelan S, Ferlay J, Raymond L, Young J, editors. Cancer Incidence in Five Continents. Lyon, IARC, 1997.
   Google Scholar
• Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001; 15: 341–54.
   PubMed Web of Science ®Google Scholar
• Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 150: 10–7.
   Google Scholar
• Ryan AJ, Susil B, Jobling TW, et al Endometrial cancer. Cell Tissue Res 2005; 322: 53–61.
   PubMed Web of Science ®Google Scholar
• Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006; 24: 4783–91.
   PubMed Web of Science ®Google Scholar
• Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer 2000; 7: 227–42.
   PubMed Web of Science ®Google Scholar
• Salvesen HB, MacDonald N, Ryan A, et al Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin Cancer Res 2000; 6: 3607–13.
   PubMed Web of Science ®Google Scholar
• Ambros RA, Sherman ME, Zahn CM, et al Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995; 26: 1260–7.
   PubMed Web of Science ®Google Scholar
• Wheeler DT, Bell KA, Kurman RJ, et al Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol 2000; 24: 797–806.
   PubMed Web of Science ®Google Scholar
• Salvesen HB, Akslen LA. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 2002; 110: 673–89.
   PubMed Web of Science ®Google Scholar
• Key T, Pike M. The dose-effect relationship between “unopposed” estrogen and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988; 57: 205–12.
   PubMed Web of Science ®Google Scholar
• Münstedt K, Grant P, Woenckhaus J, et al Cancer of the endometrium: current aspects of diagnostics and treatment. World J Surg Oncol 2004; 2: 24.
   PubMedGoogle Scholar
• Grady D. Exercise, hormone therapy and lipoproteins in women. J Am Geriatr Soc 1996; 44: 331–2.
   PubMedGoogle Scholar
• Sherman BM, Korenman SG. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab 1974; 39: 145–9.
   PubMed Web of Science ®Google Scholar
• Rogers WS, Gordon RE, Marsh MR. The incidence of malignancy in theca-cell tumors. Am J Obstet Gynecol 1952; 64: 1289–95.
   PubMedGoogle Scholar
• Hartz AJ, Rupley DC, Rimm AA. The association of girth measurements with disease in 32,856 women. Am J Epidemiol 1984; 119: 71–80.
   PubMed Web of Science ®Google Scholar
• Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973; 36: 207–14.
   PubMed Web of Science ®Google Scholar
• Silverberg SG, Mutter GL, Kurman RJ, et al Tumors of the uterine corpus: epithelial tumors and related lesions. In: Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours.Lyon: IARC Press, 2003; 221–32.
   Google Scholar
• Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985; 56: 403–12.
   PubMed Web of Science ®Google Scholar
• McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006; 59: 801–12.
   PubMed Web of Science ®Google Scholar
• Baak JP, Mutter GL. EIN and WHO94. J Clin Pathol 2005; 58: 1–6.
   PubMed Web of Science ®Google Scholar
• Lacey JV Jr, Mutter GL, Nucci MR, Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 2008; 113: 2073–81.
   PubMedGoogle Scholar
• Sherman ME, Bittermann P, Rosenschein NB, et al A morphologically diverse neoplasm with unifying clinicopathological features. Am J Surg Pathol 1992; 16; 600–10.
   PubMed Web of Science ®Google Scholar
• Fadare O, Zheng W. Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers. Diagn Pathol 2008; 3: 6.
   PubMed Web of Science ®Google Scholar
• Matias-Guiu X, Catasus L, Bussaglia E, et al Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001; 32: 569–77.
   PubMed Web of Science ®Google Scholar
• Prat J, Gallardo A, Cuatrecasas M, et al Endometrial carcinoma: pathology and genetics. Pathology 2007; 39: 72–87.
   PubMed Web of Science ®Google Scholar
• Esteller M. Dormant hypermethylated tumour suppressor genes: questions and answers. J Pathol 2005; 205: 172–80.
   PubMed Web of Science ®Google Scholar
• Risinger JI, Maxwell GL, Berchuck A, et al Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers. Ann N Y Acad Sci 2003; 983: 208–12.
   PubMed Web of Science ®Google Scholar
• Zhou XC, Dowdy SC, Podratz KC, et al Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment. Gynecol Oncol 2007; 107: 143–53.
   PubMed Web of Science ®Google Scholar
• Liao X, Siu MK, Chan KY, et al Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis. Int J Cancer 2008; 123: 296–302.
   PubMed Web of Science ®Google Scholar
• Herman JG, Umar A, Polyak K, et al Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870–5.
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 2000; 36: 2294–300.
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–54.
   PubMed Web of Science ®Google Scholar
• Furlan D, Carnevali I, Marcomini B, et al The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Clin Cancer Res 2006; 12: 3329–36.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Dowdy SC, Gonzalez Bosquet J, et al Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. Gynecol Oncol 2005; 99: 135–41.
   PubMed Web of Science ®Google Scholar
• Li R, Saito T, Tanaka R, et al Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium. Cancer Lett 2005; 219: 33–40.
   PubMed Web of Science ®Google Scholar
• Kang S, Kim JW, Kang GH, et al Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 2006; 118: 2168–71.
   PubMed Web of Science ®Google Scholar
• Arafa M, Kridelka F, Mathias V, et al High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Histopathology 2008; 53: 525–32.
   PubMed Web of Science ®Google Scholar
• Pallarés J, Velasco A, Eritja N, et al Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. Mod Pathol 2008; 21: 691–9.
   PubMed Web of Science ®Google Scholar
• Pizzi S, Azzoni C, Bottarelli L, et al RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J Pathol 2005; 206: 409–16.
   PubMedGoogle Scholar
• Youssef EM, Lotan D, Issa JP, et al Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res 2004; 10: 1733–42.
   PubMed Web of Science ®Google Scholar
• Kang S, Lee JM, Jeon ES, et al RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma. Int J Cancer 2006; 119: 1316–21.
   PubMed Web of Science ®Google Scholar
• Cheung AN. Molecular targets in gynaecological cancers. Pathology 2007; 39: 26–45.
   PubMed Web of Science ®Google Scholar
• Kanaya T, Kyo S, Maida Y, et al Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene 2003; 22: 2352–60.
   PubMed Web of Science ®Google Scholar
• Smith RA, Cokkinides V, von Eschenbach AC, et al American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002; 52: 8–22.
   PubMedGoogle Scholar
• Simsir A, Hwang S, Cangiarella J, et al Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Cancer 2003; 99: 323–30.
   PubMedGoogle Scholar
• Gu M, Shi W, Barakat RR, et al Pap smears in women with endometrial carcinoma. Acta Cytol 2001; 45: 555–60.
   PubMed Web of Science ®Google Scholar
• DuBeshter B, Deuel C, Gillis S, et al Endometrial cancer: the potential role of cervical cytology in current surgical staging. Obstet Gynecol 2003; 101: 445–50.
   PubMedGoogle Scholar
• Brown AK, Gillis S, Deuel C, et al Abnormal cervical cytology: a risk factor for endometrial cancer recurrence. Int J Gynecol Cancer 2005; 15: 517–22.
   PubMedGoogle Scholar
• Gupta JK, Chien PF, Voit D, et al Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002; 81: 799–816.
   PubMed Web of Science ®Google Scholar
• Taylor PJ, Gomel V. Endometrial ablation: indications and preliminary diagnostic hysteroscopy. Baillière's Clin Obstet Gynaecol 1995; 9: 251–60.
   PubMedGoogle Scholar
• Papaefthimiou M, Symiakaki H, Mentzelopoulou P, et al The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal women. Cytopathology 2005; 16: 32–9.
   PubMedGoogle Scholar
• Bradley WH, Boente MP, Brooker D, et al Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol 2004; 104: 1030–3.
   PubMed Web of Science ®Google Scholar
• Lerner JP, Timor-Tritsch IE, Monteagudo A. Use of transvaginal sonography in the evaluation of endometrial hyperplasia and carcinoma. Obstet Gynecol Surv 1996; 51: 718–25.
   PubMedGoogle Scholar
• Teefey SA, Stahl JA, Middleton WD, et al Local staging of endometrial carcinoma: Comparison of transvaginal and intraoperative sonography and gross visual inspection. AJR 1996; 166: 547–52.
   PubMedGoogle Scholar
• Bonilla-Musoles F, Raga F, Osborne NG, et al Three dimensional hysterosonography for the study of endometrial tumors: Comparison with conventional transvaginal sonography, hysterosalpingography and hysteroscopy. Gynecol Oncol 1997; 65: 245–52.
   PubMedGoogle Scholar
• Turnbull LW, Jumaa A, Bowsley SJ, et al Magnetic resonance imaging of the uterus after endometrial resection. Br J Obstet Gynaecol 1997; 104: 934–8.
   PubMedGoogle Scholar
• Lentz SS. Endometrial carcinoma diagnosed by positron emission tomography: a case report. Gynecol Oncol 2002; 86: 223–4.
   PubMed Web of Science ®Google Scholar
• Brosens JJ. Uterine junctional zone: function and disease. Lancet 1995; 346: 558–60.
   PubMed Web of Science ®Google Scholar
• Fiegl H, Gattringer C, Widschwendter A, et al Methylated DNA collected by tampons—A new tool to detect endometrial cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 882–8.
   PubMed Web of Science ®Google Scholar
• Mutter GL, Lin MC, Fitzgerald JT, et al Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 2000; 92: 924–30.
   PubMed Web of Science ®Google Scholar
• Lacey JV Jr, Ioffe OB, Ronnett BM, et al Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer 2008; 98: 45–53.
   PubMed Web of Science ®Google Scholar
• Lin MC, Burkholder KA, Viswanathan AN, et al Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms. Cancer 2009; 115: 2111–8.
   PubMed Web of Science ®Google Scholar